AI
Acrongenomics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Manolis Evan T, was filed 16 Mar 2009.
Acrongenomics Inc: what insiders have been doing
Acrongenomics Inc is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Acrongenomics Inc in twelve months, the latest record being from 6 May 2009.
The full history, which starts in 2008, counts 1 purchase against 1 sale.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€377
1 ops. · all time
Sell Volume
€51
1 ops. · all time
Financial data
as of FY 2010FY ended December 2010 · cache
Income statement
Net income-2.6M
Last declaration on 6 May 2009
Declarations10 total
- 3,000 shares@ US$0.45common stockSEC:0001085037-09-000213:0
- 1,500 shares@ US$0.43common stockSEC:0001085037-09-000213:1
- 2,000 shares@ US$0.238common stockSEC:0001085037-09-000136:0Canonical exit: 7 Jun 2009 (T+90)
- 400,000 shares0common stockSEC:0001085037-09-000004:0
- 250 shares@ US$0.2603common stockSEC:0001085037-08-000994:0
- 400,000 shares0common stockSEC:0001085037-08-000992:0
- 200,000 shares0Common StockSEC:0001085037-08-000920:0
- 150,000 shares0Common StockSEC:0001085037-08-000679:0
- 750,000 shares@ US$0.70Common StockSEC:0001353557-08-000001:0
- 400,000 shares@ US$0.70common stockSEC:0001353557-08-000002:0
10 of 10 declarations
About Acrongenomics Inc
Acrongenomics Inc is a company listed on the XNAS market, specializing in genomics and biotechnology. It focuses on developing innovative solutions for genetic research and diagnostics.
